3 ms·
From the article: > In about 25% of [study patients] their lung cancer had already spread to the brain when the study began. and > “Lorlatinib is the only AL
by therealcamino 2y ago
From the article:
> In about 25% of [study patients] their lung cancer had already spread to the brain when the study began.
and
> “Lorlatinib is the only ALK TKI that has reported five-year progression-free survival, and even after this time, the majority of patients continue to have their disease controlled, including control of disease in the brain.”